Silexion Therapeutics Ltd. (SLXN) vs XORTX Therapeutics Inc. (XRTX)
A side-by-side comparison of Silexion Therapeutics Ltd. and XORTX Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SLXN
Silexion Therapeutics Ltd.
$0.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XRTX
XORTX Therapeutics Inc.
$1.73HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SLXN vs XRTX
growth of $100 · dividends reinvested · last 2ySLXN -100.0% (-99.0%/yr)XRTX -77.2% (-52.2%/yr)XRTX compounded faster over this window
Log scale — wide-divergence pair
SLXN XRTX
SLXN vs XRTX: by the numbers
- •XRTX is the larger company ($481786 vs $110112 market cap).
Metrics side by side
Valuation
| Metric | SLXN | XRTX |
|---|---|---|
| P/B ratio | 2.50 | 0.09 |
Profitability
| Metric | SLXN | XRTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -31722.73% | -68.17% |
| ROIC | N/A | -71.43% |
Growth (annualized)
| Metric | SLXN | XRTX |
|---|---|---|
| Total return CAGR (5Y) | N/A | -63.52% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.